相关实验视频

Updated: May 13, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

在多中心队列中,CD26/DPP-IV抑制剂和与慢性肺异位移植功能障碍的相关性

Alexander R Graham¹, Maria V Grau-Sepulveda², Erika J Bush Buckley¹

¹Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

|April 29, 2025

概括

肺移植后早期使用CD26抑制剂 (gliptins) 可能减少慢性肺异位移植功能障碍 (CLAD). 在90天内长时间暴露,有望预防CLAD发展和相关并发症.

科学领域:

免疫学免疫学免疫学
移植医学移植医学
药理学药理学是指药理学的学科.

背景情况:

慢性肺异位移植功能障碍 (CLAD) 是肺移植后的一个主要并发症.
CD26/二基酶4抑制剂 (gliptins) 调节涉及CLAD的炎症途径.
了解平素在CLAD中的作用对于改善长期移植结果至关重要.

研究的目的:

调查平素暴露与肺移植接受者中CLAD的发展之间的关联.
分析来自多个北美移植中心的纵向临床数据.
为了确定早期或长期使用平素是否会影响CLAD风险.

主要方法:

分析了来自6个北美中心的779名首次肺移植接受者的队列.
数据包括平素暴露,CLAD风险因素和2021年6月的随访.
考克斯回归模型评估了可能的CLAD,CLAD相关死亡或再移植的复合终点.

主要成果:

整体平素暴露与CLAD没有关联.
随时分析显示,移植后90天内,超过6个月的暴露降低了确定的CLAD风险 (HR 0.25;95% CI,0.07-0.83).
16.2%的患者接受了gliptins,而29.9%的患者经历了复合的CLAD结果.

结论:

Gliptins 和 CLAD 之间的关系是复杂的.
早期启动gliptins (在90天内) 和长期使用可能会提供对CLAD的保护.
需要进一步的研究来证实这些发现,并优化肺移植中gliptin治疗.

关键词:

在CD2626中,我们可以看到CD26.这就是CLAD.在 DPP-IV 中,草甘的使用方法肺肺肺肺肺肺肺肺肺拒绝拒绝拒绝拒绝移植移植移植移植移植移植

更多相关视频

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

相关概念视频

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...